Pharmaceutical innovation continues generating groundbreaking therapeutic interventions addressing significant unmet medical needs across diverse disease categories. Elafibranor has gained recognition as a promising treatment candidate for intricate liver and metabolic conditions, notably non-alcoholic steatohepatitis (NASH). DelveInsight's detailed analysis of the Elafibranor Market offers...